CR VENTURES MANAGEMENT, LLC
CR VENTURES MANAGEMENT, LLC is a Series A, Series C+ and other fund in Global investing in pharmaceuticals, diagnostics, medical-technology, biotechnology and biopharmaceutical.
- Stages
- Series A, Series C+, other
- Sectors
- pharmaceuticals, diagnostics, medical-technology, biotechnology, biopharmaceutical
- Invests in
- Global
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $114M
- Website
- cr-ventures.com
Check size not disclosed
Thesis
CR Ventures Management, LLC, operating as CR Ventures, is a global life-science investor exclusively focused on companies seeking funding for their clinical trials. They do not invest in pre-clinical rounds, preferring to support companies that have advanced to the clinical trial stage in pharmaceuticals, diagnostics, and other medical technologies. Their investment thesis centers on the life sciences sector, targeting companies in pharmaceutical, diagnostic, and medical technology fields requiring clinical trial funding. The firm's geographic scope is global, with offices in Boston and Europe, and they invest worldwide. CR Ventures appears to act as a lead investor, indicated by their participation in funding rounds and partnerships with research organizations. Their preference for clinical-stage companies suggests a focus on later-stage venture or growth-stage investments. The firm has five private funds with a total gross asset value of $114 million, with one Venture Capital Fund valued at $113,982,249. CR Ventures operates as an Exempt Reporting Adviser (ERA).
Common questions
Does CR VENTURES MANAGEMENT, LLC invest at the Series A stage?
Yes. CR VENTURES MANAGEMENT, LLC lists Series A, Series C+ and other among the stages it invests in.
Where does CR VENTURES MANAGEMENT, LLC invest?
CR VENTURES MANAGEMENT, LLC invests in Global.